[What's new in internal medicine?]

Area of Science:

• Internal Medicine
• Immunology
• Microbiology

Background:

• Inflammatory myopathies present diverse clinical features and variable treatment responses.
• Gut microbiota alterations are increasingly linked to autoimmune diseases, requiring further investigation.
• The interplay between obesity, metabolic syndrome, atherosclerosis, and autoimmune conditions is a critical area of research.

Purpose of the Study:

• To summarize recent advancements in internal medicine, focusing on key areas of autoimmune and inflammatory conditions.
• To highlight the significance of gut microbiota in disease development and progression.
• To explore the complex relationships between metabolic health and autoimmune disorders.

Main Methods:

• Review of current literature and recent data on selected topics in internal medicine.
• Synthesis of information on inflammatory myopathies, gut dysbiosis, and metabolic-autoimmune links.
• Inclusion of new findings on systemic sclerosis, vasculitis, and specific autoantibodies.

Main Results:

• Inflammatory myopathies are a heterogeneous group with wide-ranging clinical and immunological profiles.
• Gut dysbiosis plays a role in various conditions, including autoimmune diseases.
• Obesity, metabolic syndrome, and atherosclerosis are interconnected with autoimmune diseases.

Conclusions:

• Understanding the heterogeneity of inflammatory myopathies is crucial for tailored treatment.
• Further research into gut microbiota's role in autoimmune diseases is warranted.
• The intricate relationship between metabolic factors and autoimmunity requires continued study for comprehensive patient care.